Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
72.11%
Operating Margin
71.35%
Net Margin
126.16%
Efficiency Metrics
Revenue per Expense Ratio
3.49
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.6900000000
Balance Sheet Analysis
Current Ratio
0.54
Cash Ratio
1.48
Working Capital
$-1.17M
Debt to Equity
0.00
Debt to Assets
0.00%
Equity Ratio
99.35%
Cash Flow Analysis
Operating Cash Flow Ratio
119.18%
Free Cash Flow Ratio
119.18%
CapEx to Revenue
0.00%
Dividends Paid
$21.60M
Stock Buybacks
$7.67M
Total Shareholder Returns
$29.27M
Cash Position Change
180.13%
Key Takeaways (2023 FY)
Revenue declined by 87.20516738079%, indicating potential market challenges
Increased dividend payments by 39.14%
Detailed Growth Metrics
Core Performance
Revenue
-87.21%
Net Income
-83.82%
EPS
-82.84%
Operating Income
-90.85%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
2,390.40%
Operating Cash Flow
3.70%
Free Cash Flow
3.70%
Balance Sheet Health
Assets
-2.92%
Debt
-100.00%
Book Value per Share
3.30%
Inventory
100.00%
Shareholder Returns
Dividends per Share
39.14%
Shares Outstanding
-5.74%
Long Term Trends
3Y Revenue/Share
114.22%
5Y Revenue/Share
119.15%
3Y Dividend/Share
20.11%
5Y Dividend/Share
-13.06%